期刊文献+

子痫前期相关血清标志物研究进展 被引量:2

下载PDF
导出
摘要 子痫前期筛查是常规产前保健的重要组成部分。传统的筛查主要集中于对产妇病史、高血压、蛋白尿和水肿的监测。近年来,发现了许多与子痫前期发生发展相关的生物标记物。本文就最有希望的子痫前期相关血清标志物的生物机能、临床应用以及预测子痫前期,监测病情发展的灵敏度与特异性等方面做一综述,为开发子痫前期的筛选试验提供证据。
出处 《西部医学》 2012年第12期2431-2433,共3页 Medical Journal of West China
基金 国家自然科学基金面上项目(编号:81170576)
  • 相关文献

参考文献21

  • 1Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J]. Hypertension, 2007, 50(1) :137-142.
  • 2Leslie K, Thilaganathan B, Papageorghiou A. Early prediction and prevention of pre-eclampsia[J]. Best Pract Res Clin Obstet Gynaecol, 2011, 25(3):343-354.
  • 3Tripathi R, Rath G, Jain A, Salhan S. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia[J]. Ann Anat, 2008, 190 (5) :477-489.
  • 4Levine RJ, Lam C, Qian C et al. Soluble Endoglin and Other Circulating Antiangiogenie Factors in Preeelampsia[J]. N Engl J Med, 2006,355(10) :992-1005.
  • 5Verlohren S, Galindo A, Schlembaeh D et al. An automated method for the determination of the sFIt-1/PIGF ratio in the as- sessment of preeclampsla[J]. Am J Obstet Gynecol, 2010,202 (2) :161. e1-161, e11.
  • 6Boldt HB, Conover CA. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailahility through cleavage of IGFBPs[J]. Growth Horm IGF Res, 2007, 17(1) : 10-18.
  • 7Sifakis S, Akolekar R, Kappou D etal. Maternal serum insulinlike growth factor-binding protein-1 (IGFBP-1) at 11-1:3 weeks in pre-eclampsia[J]. Prenat Diagn,2011, 31(2) :196-201.
  • 8Grimpel YI, Kivity V, Cohen A et al. Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants[J]. Placenta, 2011, 32 Suppl: S55-S64.
  • 9Shimizu H, Sekizawa A, Purwosunu Yet al. PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia[J]. Prenat Diagn, 2009,29(13) :1231-1236.
  • 10Sammar M, Nisemblat S, Fleischfarb Z et al. Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery[J]. Pla- centa, 2011, 32 Suppl:S30-S36.

二级参考文献8

  • 1Kallio PJ, Wilson WJ, O'Brien S, et al. Regulation of the hypoxiainducible transcription factor l alpha by the ubiquitin-proteasome pathway. Biol Chem, 1999,274:6519-6525.
  • 2Schaffer L, Scheid A, Spielmann P, et al. Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta, 2003, 24:941-950.
  • 3Shore L, Wang TH, Wang CL, et al. Vascular endothelium growth factor, placenta growth factor and their receptors in isolated human trophoblasts. Placenta, 1997,18:651-665.
  • 4Chun JY, Song Y. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J Clin Endocrinol Metab, 2004, 89:2484-2490.
  • 5Regnauh TR, Orbus RJ, Vriji B, et al. Placental expression of VEGF, PIGF and their receptors in a model of placental insufficiency-intrauterine restriction. Placenta, 2002, 23:132-144.
  • 6Nagamasu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen:an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinol, 2004, 145 : 4835-4837.
  • 7Ahmad S. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis. Endothelium,2005,12:89-95.
  • 8Rajakumar A, Brandon HM. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placenta. Placenta, 2004, 25:763-769.

共引文献10

同被引文献32

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部